University of Cambridge Department of Surgery, Addenbrooke's Hospital, Cambridge, UK.
The NIHR Blood and Transplant Research Unit (BTRU) at the University of Cambridge in collaboration with Newcastle University and in partnership with NHS Blood and Transplant (NHSBT), Cambridge, UK.
Clin Transplant. 2020 Aug;34(8):e13982. doi: 10.1111/ctr.13982. Epub 2020 Jun 10.
Donation after circulatory death (DCD) liver transplantation is associated with higher rates of graft loss. In this paper, we explored whether the Model for Early Allograft Function (MEAF) predicted outcome in DCD liver transplantation. We performed a retrospective analysis of prospectively collected data from all adult DCD (Maastricht 3) livers transplanted in Cambridge and Edinburgh between 1 January 2011 and 30 June 2017, excluding those undergoing any form of machine perfusion. 187 DCD liver transplants were performed during the study period. DCD liver transplants with a lower MEAF score had a significantly better survival compared to those with a high MEAF score (Mantel-Cox P < .0001); this was largely due to early graft loss. Beyond 28 days post-transplant, there were no significant long-term graft or patient survival differences irrespective of the grade of MEAF (Mantel-Cox P = .64 and P = .43, respectively). The MEAF score correlated with the length of ICU (P = .0011) and hospital stay (P = .0007), but did not predict the requirement for retransplantation for ischemic cholangiopathy (P = .37) or readmission (P = .74). In this study, a high MEAF score predicted early graft loss, but not the subsequent need for re-transplantation or late graft failure as a result of intrahepatic ischemic bile duct pathology.
在循环死亡(DCD)供肝肝移植中,移植物丢失率较高。在本文中,我们探讨了早期移植物功能模型(MEAF)是否可以预测 DCD 肝移植的结局。我们对 2011 年 1 月 1 日至 2017 年 6 月 30 日期间在剑桥和爱丁堡进行的所有成人 DCD(马斯特里赫特 3 期)供肝移植的前瞻性数据进行了回顾性分析,排除了任何形式的机器灌注。研究期间共进行了 187 例 DCD 肝移植。MEAF 评分较低的 DCD 肝移植患者的存活率明显优于 MEAF 评分较高的患者(Mantel-Cox P<.0001);这主要是由于早期移植物丢失。移植后 28 天以上,无论 MEAF 分级如何,均无显著的长期移植物或患者存活率差异(Mantel-Cox P=.64 和 P=.43)。MEAF 评分与 ICU (P=.0011)和住院时间(P=.0007)的长短相关,但与缺血性胆管病(P=.37)或再入院(P=.74)的再移植需求无关。在这项研究中,高 MEAF 评分预测早期移植物丢失,但不能预测因肝内缺血性胆管病变而需要再次移植或晚期移植物衰竭。